35 patents
Page 2 of 2
Utility
Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
30 Nov 20
The present invention relates to compositions comprising fractionated alkylated cyclodextrin compositions having a single degree of substitution, and processes for preparing and using the same.
Vincent D. Antle, Charles Alan Watson, David W. Miles
Filed: 20 Aug 15
Utility
Compositions Containing Silymarin and Sulfoalkyl Ether Cyclodextrin and Methods of Using the Same
21 Oct 20
Cosmetic and dietary supplement compositions containing silymarin and sulfoalkyl ether cyclodextrin, particularly sulfobutyl ether cyclodextrin, are described.
James D. Pipkin, Roger A. Rajewski, Beau Mainous
Filed: 1 Jul 20
Utility
pnkfh22yjvx8ews2ikmnr647egaau sicx1giqqx
12 Oct 20
An inhalable formulation containing SAE-CD and corticosteroid is provided.
James D. Pipkin, Rupert O. Zimmerer, Diane O. Thompson, Gerold L. Mosher
Filed: 4 Dec 18
Utility
gi88cj17lwqgpa3mgpv9 tv
12 Oct 20
The present invention related to low-chloride alkylated cyclodextrin compositions, along with processes for preparing and using the same.
Vincent D. Antle, Álvaro Lopes, Daniel Monteiro
Filed: 1 Aug 18
Utility
2vwgp0okedb7vac1a15eez
21 Sep 20
SAE-CD compositions are provided, along with methods of making and using the same.
Vincent D. Antle
Filed: 4 Nov 18
Utility
h5sbmjt7imb6tj21xx8fnp902oeek9u3e3
2 Sep 20
An inhalable dry powder formulation containing SAE-CD and an active agent is provided.
James D. Pipkin, Gerold L. Mosher, Douglas B. Hecker
Filed: 14 May 20
Utility
sorjnfl0cgc8z etc5dzbjhzav06ftq
26 Aug 20
The present disclosure is directed to pharmaceutical compositions comprising a nitrogen mustard and a cyclodextrin derivative, and methods of making and using the same.
James D. Pipkin, Stephen G. Machatha
Filed: 26 Dec 19
Utility
yfzvhbut3lr4fr1kl2swzittvasycwl9a1yzt7il27fcojun46uau4xf
6 Jul 20
Cosmetic and dietary supplement compositions containing silymarin and sulfoalkyl ether cyclodextrin, particularly sulfobutyl ether cyclodextrin, are described.
James D. Pipkin, Roger A. Rajewski, Beau Mainous
Filed: 17 Mar 16
Utility
c47xw2wmfhuol5bai53sky7w5nak794r6n0hq1dizu9sqj9mwz
6 Jul 20
A particulate SAE-CD composition is provided.
James D. Pipkin, Gerold L. Mosher, Douglas B. Hecker
Filed: 7 Feb 19
Utility
423ofvfhzvadj53vl4i6o gy9ovoik7p4yyx
10 Jun 20
An aqueous composition of latanoprost and SAE-CD is provided.
Naomi Esaki, James D. Pipkin
Filed: 31 Oct 19
Utility
j70s3j nq8fvvots0rrqy9idi
1 Jun 20
An inhalable dry powder formulation containing SAE-CD and an active agent is provided.
James D. Pipkin, Gerold L. Mosher, Douglas B. Hecker
Filed: 21 Dec 11
Utility
ga13be0r1398pxs7 ouhoy7
20 May 20
A process and equipment assembly for reacting a substituent precursor with a cyclodextrin starting material to provide a raw product comprising a cyclodextrin derivative and 1% or less of an initial amount of the substituent precursor is provided.
Vincent D. Antle, Jose R. Matos
Filed: 23 Jan 20
Utility
uurradqe h5czatzkh69b
27 Apr 20
A process and equipment assembly for reacting a substituent precursor with a cyclodextrin starting material to provide a raw product comprising a cyclodextrin derivative and 1% or less of an initial amount of the substituent precursor is provided.
Vincent D. Antle, Jose R. Matos
Filed: 30 Aug 17
Utility
ohrgtuznbm967qz98ub9fez70l4e
23 Dec 19
The present invention provides compositions containing clopidogrel, present as a free base or a pharmaceutically acceptable salt thereof, and sulfoalkyl ether cyclodextrin (SAE-CD).
Gerold L. Mosher, Rebecca L. Wedel, Karen T. Johnson, Stephen G. Machatha, Jane A. Cowee, Daniel J. Cushing
Filed: 23 Jul 18
Utility
2iatx6890qd3x1txq4 60g5su6
4 Nov 19
An aqueous composition of latanoprost and SAE-CD is provided.
Naomi Esaki, James D. Pipkin
Filed: 6 Nov 08